BeStock  
Markets › Compare › MLTX vs KURA

MLTX vs KURA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
MLTX · MoonLake Immunotherapeutics$10.77 ▼ 1.64%
KURA · Kura Oncology$10.67 ▲ 1.33%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

62108154200246Oct 9, '25Apr 9, '26Oct 7, '26
  • MLTX +14.8%
  • KURA +4.1%

Head to head

MetricMLTXKURA
Price$10.77$10.67
Change today▼ 1.64%▲ 1.33%
Market cap$916.60M$949.21M
Return, 3 months-46.0%-11.7%
Return, year to date-18.3%+2.7%
Return, 1 year+18.4%+5.9%
P/E (TTM)-2.8-3.2
P/B2.119.6
P/E percentile vs own 5y90th85th
Dividend yield––
Revenue growth (YoY, latest qtr)–+36.5%
Net profit growth (YoY)-10.3%-3.3%
Gross margin–99.3%
Operating margin–-411.9%
Net margin–-384.3%
Return on equity-67.4%-167.7%
Analyst target vs. price+220.3%+166.5%
Analyst buy share100%100%
RSI (14)2541
30-day volatility46.4%38.1%
Max drawdown, 1 year-89.9%-39.0%
Trend readStrong downtrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • KURA is the largest of the group by market value.
  • MLTX has returned the most over the past year.
  • KURA carries the lowest trailing P/E.
  • KURA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top